Order Article Reprints

Kolokotronis T, Majchrzak-Stiller B, Buchholz M, Mense V, Strotmann J, Peters I, Skrzypczyk L, Liffers S-T, Menkene LM, Wagner M, et al. Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. Cancers. 2024; 16(15):2726. https://doi.org/10.3390/cancers16152726

Kolokotronis, Theodoros, Britta Majchrzak-Stiller, Marie Buchholz, Vanessa Mense, Johanna Strotmann, Ilka Peters, Lea Skrzypczyk, Sven-Thorsten Liffers, Louise Massia Menkene, Mathias Wagner, and et al. 2024. "Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma" Cancers 16, no. 15: 2726. https://doi.org/10.3390/cancers16152726

Kolokotronis, T., Majchrzak-Stiller, B., Buchholz, M., Mense, V., Strotmann, J., Peters, I., Skrzypczyk, L., Liffers, S.-T., Menkene, L. M., Wagner, M., Glanemann, M., Betsou, F., Ammerlaan, W., Schmidt, R., Schröder, C., Uhl, W., Braumann, C., & Höhn, P. (2024). Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. Cancers, 16(15), 2726. https://doi.org/10.3390/cancers16152726